XNYS: MRK
Merck & Company Live Stock Price Today, Share Analysis and Chart
about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to ov...
Read More
135.21
-0.34
(-0.25%)
988.7K
XNYS Volume
XNYS 14 Aug, 2026 10:22 AM (EDT)
Analyst Upgrade
Daiwa Capital upgrades Merck & Co to an 'Outperform' rating; raises the target price to $143
See details
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..